Definitive Contract HHSN268201600006C
Award Date 10/23/15
Potential Completion Date 9/28/18
Potential Value $1.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Monmouth Junction, South Brunswick Township, NJ 08852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $999,996.59 firm-fixed-price Phase II SBIR contract awarded by the Joint PEO Chemical and Biological Defense to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for research and prototype development services related to Cytosorbents' blood purification technologies, including an extracorporeal cytokine adsorber, a potassium adsorber, and a blood group antibody adsorber. These technologies are intended to treat critical care...
- This is a firm fixed-price purchase order awarded by the Joint Program Executive Office for Chemical and Biological Defense, a U.S. Department of Defense agency, to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The $149,935.98 contract is for research and prototype development services under the Small Business Innovation Research (SBIR) Phase I program. The contract is set aside for small businesses. Cytosorbents Medical Inc., the prime contractor,...
- This federal contract award, with a ceiling value of $149,927.17, was issued by the U.S. Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for a SBIR Phase I research project under the Defense Health Program (DHP), with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business set-aside, Cytosorbents is the prime contractor responsible for conducting the research to...
- This is a $149,979 firm-fixed-price Definitive Contract awarded by the United States Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract was awarded under the Small Business Innovation Research (STTR) program for Phase I research, with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business, this contract award was set aside for Cytosorbents as the prime...
- Cytosorbents Medical Inc., doing business as Cytosorbents and classified as a small disadvantaged business, has been awarded a $74,918 firm fixed price purchase order by the Department of the Air Force Materiel Command Research Laboratory. The contract is set aside for total small business and involves research and development of a novel sorbent technology for the rapid treatment of acute joint injury and inflammation under the Small Business Innovation Research Program Phase I. Work will be...
- This $1.1 million firm fixed price contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, to support research and development of an adsorber to remove anti-A and anti-B antibodies from plasma for transfusion under the Small Business Innovation Research (SBIR) Program Phase II solicitation. As a total small business set-aside, the contract aims to further the prime contractor's development of an effective adsorber that...
- This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to New Health Sciences, Inc. (doing business as Hemanext Inc.), a small business manufacturer. The $1,660,011.00 contract is for the development of a novel, low-cost blood storage system that will deliver higher quality red blood cells, thereby reducing the harmful consequences of transfusion therapy. This contract is part of the SBIR (Small Business Innovation Research) Phase I program, under...
- The Air Force has awarded a $2,959,747 cost-plus-fixed-fee contract to Cytosorbents Medical Inc. to provide the K+ONTROL Renal Support System for Reduction of Hyperkalemia. This definitive contract has an ultimate completion date of September 27, 2023. Cytosorbents is a for-profit manufacturer that develops blood purification technologies to treat critical care conditions. The company has previously received research and development funding from the National Institutes of Health and Department...
- This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
- The U.S. Army Medical Command awarded a $4.3M Phase III Small Business Innovation Research (SBIR) contract to Cytosorbents Medical Inc. on August 22, 2022, for research and development of a universal dried plasma product designed for battlefield and first responder use. The contract, which carries a firm fixed-price structure and is set aside for small business, focuses on integrating isoagglutinin reduction technology to enable universal blood transfusions in emergency and combat scenarios....